Legislation with proposals that drug firms were hesitant to get behind – reforming FDA's OTC drug monograph program and establishing a user fee program to support the agency's work – is close to surfacing in Congress with the industry's backing.
OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA
Imminent OTC monograph reform legislation signals an agreement between industry and FDA on details of a proposal, which also includes a potential user fee program. CHPA also is hopeful for legislation restoring direct OTC drug purchases with pre-tax savings accounts.
